Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences:

Read more at globenewswire.com